Deborah Jeanfavre

Editorial Analyst Views expressed are my own.

[Deborah Jeanfavre @CitelineDeborJ]

Come to @Pharma intelligence | informa for your Topline Trial Landscape, completed in 2018 #pharma #intelligence #informa https://t.co/ZTWYpvHj4K

[Deborah Jeanfavre @CitelineDeborJ]

Always stay current with topics of most interest to you @Pharma intelligence | informa for the best, informed decisions... https://t.co/BAaCSV12aV

[Deborah Jeanfavre @CitelineDeborJ]

https://t.co/EZqaISwiVO

[Deborah Jeanfavre @CitelineDeborJ]

https://t.co/6MipRCbuyy

[Deborah Jeanfavre @CitelineDeborJ]

Great information #Citeline from Judy Adair, supporting the celebration of current progress and renewed focus on treatments for #parkinsonsawarenessmonth #parkinsons https://t.co/mVnk99h7Sx

[Deborah Jeanfavre @CitelineDeborJ]

https://t.co/mpsMZiM9se

[Deborah Jeanfavre @CitelineDeborJ]

https://t.co/n59eyKpgYd

[Deborah Jeanfavre @CitelineDeborJ]

What to expect for Key Drugs, looking forward from Q1 in 2019? Get the scoop here - Informa's @Pharma Intelligence experts https://t.co/vG5BFL1owO

[Deborah Jeanfavre @CitelineDeborJ]

Put this at the TOP of your schedule for February 14th - REAL WORLD EVIDENCE. https://t.co/EpYEpCNxrT

[Deborah Jeanfavre @CitelineDeborJ]

Don't miss our analysts' most current analysis of Opioid abuse-deterrent drug development @Pharma intelligence | informa https://t.co/SoXUXd1wxh

[Deborah Jeanfavre @CitelineDeborJ]

Have you heard ‘CARE Awards 2019 - Why Enter’ by Pharma Intelligence on #SoundCloud? #np https://t.co/cu8v1rmAFb

[Deborah Jeanfavre @CitelineDeborJ]

Take the time - don't miss this opportunity to Celebrate #CAREAwards

[Citeline Awards @Citeline_Awards]

4 Days remain! Listen to our #podcast to find out WHY you should enter the 2019 #CAREAwards! But hurry - entries close on Friday! https://t.co/SLtfTQWjFO

[Deborah Jeanfavre @CitelineDeborJ]

Don'tmiss this interesting piece of analysis by Laura Runkel Citeline https://t.co/LBisnetdha

[Deborah Jeanfavre @CitelineDeborJ]

https://t.co/YNizODgQqA

[Scrip, Citeline Commercial @PharmaScrip]

Join us on November 14th at 4pm (GMT) / 11am (EDT) to find out more about how originator companies face up to the biosimilar challenge. Register here https://t.co/074jxoe3g9 #webinar

[Deborah Jeanfavre @CitelineDeborJ]

https://t.co/GpwxqrpAaD

[Deborah Jeanfavre @CitelineDeborJ]

Are biosimilars on your radar? Don't miss this Informa @Pharma_Intell webinar.

[Karen Currie @CitelineKarenC]

How are biosimilar originator companies are responding to threats to their profit margins? Join the upcoming webinar from Informa Pharma Intelligence to find out.

[Deborah Jeanfavre @CitelineDeborJ]

Take a look at @Pharma_Intell Partnering Trends.

[Citeline @Citeline]

Our continued collaboration with #EBDGroup has seen the development of the 2018 Partnering Trends report. Download your copy here today https://t.co/byjrMep5Ix

[Citeline @Citeline]

Choose from API integration or custom analytics that deliver personalised & dynamic visualisation solutions https://t.co/NPnNOiYiDD

[Deborah Jeanfavre @CitelineDeborJ]

Let's get clinical - join our experts in November...

[Citeline @Citeline]

Join leading #earlyclinical experts this November for insights on enhancing your #earlyphase #clinical development strategy at #EarlyClinicalDevelopment 2018, part of #PCTrials. Find out more: https://t.co/AqJoYSzliU #EarlyClinical #PhaseITrials #ClinicalTrials @ClinTrials365